Skip to main content
. 2012 Feb 29;7(2):e31980. doi: 10.1371/journal.pone.0031980

Table 2. Changes in personality scores in the escitalopram and the placebo group following four weeks of treatment.

Personality trait(4 weeks -entry) Interventiongroup Mean (SD) Median Minimumvalue Maximumvalue Interquartile range p
Neuroticismc Escitalopram −1.77 (3.74) −1 −9 12 4
Placebo −2.08 (2.86) −2 −9 4 4 0.73b
Neuroticismd Escitalopram −3.01 (10.3) −4 −31 19 10
Placebo 1.00 (10.5) 1 −21 27 16 0.09a
Extraversiond Escitalopram 1.51 (7.95) 2 −16 18 10 0.90a
Placebo 1.32 (6.24) 2 −15 15 8
Opennessd Escitalopram 3.18 (9.84) 5 −30 20 8 0.33b
Placebo 2.15 (9.97) 3 −17 38 14
Agreeablenessd Escitalopram 2.38 (8.09) 1 −18 19 11 0.046a
Placebo −1.32 (7.94) −3 −15 18 11
Conscientiousnessd Escitalopram 1.85 (8.41) 2 −12 20 14 0.07a
Placebo −2.34 (11.4) −1 −42 14 14
a

) The distributions did not differ significantly from the normal distribution (Shapiro Wilkes test) and a t-test was used to compare the escitalopram and the placebo arm. P of Levene's test ranged from 0.11 to 0.80.

b

) The distributions differed from the normal distribution but judged from the graphical displays (histograms and probability distributions) they followed normal distributions with reasonable approximation, thus a t-test was also used.

c

) Eysenck: Escitalopram (n = 39), placebo (n = 37).

d

) NEO-PI-R: Escitalopram (n = 39), placebo (n = 38).